Silvia Deaglio

Department of Medical Sciences, University of Turin

Research Area

Biography

Silvia Deaglio has not added Biography.
If you are Silvia Deaglio and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 5	2016

Other Publications

Article	Year
Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil. Haematologica\| PubMed ID: 11836173	2002
Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells. Blood\| PubMed ID: 11895784	2002
Oxytocin is a growth factor for Kaposi's sarcoma cells: evidence of endocrine-immunological cross-talk. Cancer research\| PubMed ID: 11956104	2002
Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects. Breast cancer research and treatment\| PubMed ID: 12083632	2002
Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum. Blood\| PubMed ID: 12393650	2002
Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia. Blood\| PubMed ID: 12456497	2003
Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120. FASEB journal : official publication of the Federation of American Societies for Experimental Biology\| PubMed ID: 12551845	2003
Simultaneous expression of CD38 and its ligand CD31 by chronic lymphocytic leukemia B-cells: anecdotal observation or pathogenetic hypothesis for the clinical outcome? Haematologica\| PubMed ID: 12651280	2003
Role of CD31/platelet endothelial cell adhesion molecule-1 expression in in vitro and in vivo growth and differentiation of human breast cancer cells. The American journal of pathology\| PubMed ID: 12651608	2003
CD38 ligation plays a direct role in the induction of IL-1beta, IL-6, and IL-10 secretion in resting human monocytes. Cellular immunology\| PubMed ID: 12718937	2002
CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood\| PubMed ID: 12763926	2003
Death of T cell precursors in the human thymus: a role for CD38. International immunology\| PubMed ID: 12917263	2003
Transferrin receptor 2 protein is not expressed in normal erythroid cells. The Biochemical journal\| PubMed ID: 15084147	2004
CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood\| PubMed ID: 15613544	2005
Immunodetection of anti-MAG IgM antibody by cross-reactivity to LA-N-1 neuroblastoma cells. Journal of neuroimmunology\| PubMed ID: 15748946	2005
CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells. Blood\| PubMed ID: 16293598	2006
In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia. Blood\| PubMed ID: 16621959	2006
TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway. Journal of cell science\| PubMed ID: 17046995	2006
CD38/CD19: a lipid raft-dependent signaling complex in human B cells. Blood\| PubMed ID: 17327405	2007
CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity. Molecular medicine (Cambridge, Mass.)\| PubMed ID: 17380201	2006
The CD38 ectoenzyme family: advances in basic science and clinical practice. Molecular medicine (Cambridge, Mass.)\| PubMed ID: 17380202	2006
Transferrin receptor 2 is frequently expressed in human cancer cell lines. Blood cells, molecules & diseases\| PubMed ID: 17428703	2007
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. The Journal of experimental medicine\| PubMed ID: 17502665	2007
Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia. American journal of hematology\| PubMed ID: 17534928	2007
CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential. Blood\| PubMed ID: 17699742	2007
Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4. Haematologica\| PubMed ID: 18024373	2007
CD38 at the junction between prognostic marker and therapeutic target. Trends in molecular medicine\| PubMed ID: 18403265	2008
CD39 and control of cellular immune responses. Purinergic signalling\| PubMed ID: 18404431	2007
The CD38/CD157 mammalian gene family: An evolutionary paradigm for other leukocyte surface enzymes. Purinergic signalling\| PubMed ID: 18404481	2006
CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome? Blood\| PubMed ID: 18424664	2008
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiological reviews\| PubMed ID: 18626062	2008
Regulation of transferrin receptor 2 in human cancer cell lines. Blood cells, molecules & diseases\| PubMed ID: 19019709	2009
CD38 and CD157 ectoenzymes mark cell subsets in the human corneal limbus. Molecular medicine (Cambridge, Mass.)\| PubMed ID: 19052657	2009
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Cancer research\| PubMed ID: 19383907	2009
Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferation. Haematologica\| PubMed ID: 19483151	2009
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 19509140	2009
Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance. Journal of translational medicine\| PubMed ID: 19715592	2009
TfR2 expression in human colon carcinomas. Blood cells, molecules & diseases\| PubMed ID: 19729324	2009
CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells. Molecular medicine (Cambridge, Mass.)\| PubMed ID: 19956559	2010
Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38. Haematologica\| PubMed ID: 20207849	2010
Monocytes/macrophages but not T lymphocytes are the major targets of the CCL3/CCL4 chemokines produced by CD38(+)CD49d(+) chronic lymphocytic leukaemia cells. British journal of haematology\| PubMed ID: 20346010	2010
Transferrin receptor 2 is frequently and highly expressed in glioblastomas. Translational oncology\| PubMed ID: 20360937	2010
The hidden life of NAD+-consuming ectoenzymes in the endocrine system. Journal of molecular endocrinology\| PubMed ID: 20660167	2010
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. Hematological oncology\| PubMed ID: 20669154	2011
CD38 as a molecular compass guiding topographical decisions of chronic lymphocytic leukemia cells. Seminars in cancer biology\| PubMed ID: 20817095	2010
Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients. European journal of haematology\| PubMed ID: 20846302	2010
Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease. Leukemia research\| PubMed ID: 20880586	2011
Variable impact of CD39 in experimental murine colitis. Digestive diseases and sciences\| PubMed ID: 20936356	2011
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome. British journal of haematology\| PubMed ID: 21121903	2011
Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells. Cell research\| PubMed ID: 21403679	2011
NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model. FEBS letters\| PubMed ID: 21514298	2011
A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine. FEMS immunology and medical microbiology\| PubMed ID: 21535228	2011
Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk. British journal of haematology\| PubMed ID: 21554262	2011
Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network. Cancer research\| PubMed ID: 21565980	2011
Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Advances in pharmacology (San Diego, Calif.)\| PubMed ID: 21586363	2011
CD38 and chronic lymphocytic leukemia: a decade later. Blood\| PubMed ID: 21765022	2011
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma. Blood\| PubMed ID: 21881048	2011
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death. Blood\| PubMed ID: 21998208	2011
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood\| PubMed ID: 22039264	2011
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood\| PubMed ID: 22077063	2012
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expre... Haematologica\| PubMed ID: 22207686	2012
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia. Blood\| PubMed ID: 22308293	2012
A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia. American journal of hematology\| PubMed ID: 22460620	2012
Microenvironmental interactions in chronic lymphocytic leukemia: hints for pathogenesis and identification of targets for rational therapy. Current pharmaceutical design\| PubMed ID: 22591383	2012
Different aquaporin-4 expression in glioblastoma multiforme patients with and without seizures. Molecular medicine (Cambridge, Mass.)\| PubMed ID: 22714714	2012
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. The Journal of experimental medicine\| PubMed ID: 22891273	2012
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options. Cancer letters\| PubMed ID: 22910767	2013
Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseases. Mediterranean journal of hematology and infectious diseases\| PubMed ID: 22973497	2012
Chronic lymphocytic leukemia after chronic myeloid leukemia in the same patient: two different genomic events and a common treatment? Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 23008321	2012
Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states. Journal of molecular medicine (Berlin, Germany)\| PubMed ID: 23292173	2013
The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia. Haematologica\| PubMed ID: 23300177	2013
The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation. Haematologica\| PubMed ID: 23349302	2013
rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia? British journal of haematology\| PubMed ID: 23668599	2013
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey. Leukemia & lymphoma\| PubMed ID: 23829282	2014
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia. Current topics in medicinal chemistry\| PubMed ID: 24171772	2013
HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism. Haematologica\| PubMed ID: 24362551	2014
Anti-CD44 mAb for the treatment of B-cell chronic lymphocytic leukemia and other hematological malignancies: evaluation of WO2013063498. Expert opinion on therapeutic patents\| PubMed ID: 24798704	2014
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. Blood\| PubMed ID: 25368373	2015
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia. Haematologica\| PubMed ID: 25398834	2015
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts. Blood\| PubMed ID: 26463425	2016
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response. The Journal of clinical investigation\| PubMed ID: 26619119	2016
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death. Scientific reports\| PubMed ID: 27221966	2016
miR-214 and miR-148b targeting inhibits dissemination of melanoma and breast cancer. Cancer research\| PubMed ID: 27328731	2016
The genetics of nodal marginal zone lymphoma. Blood\| PubMed ID: 27335277	2016